International Biotechnology Trust’s Cogent Biosciences COGT Stock Holding History

International Biotechnology Trust’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.31M	Buy	+135,000	New	+$1.6M	0.44%	45

Other funds holding COGT

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

International Biotechnology Trust's COGT Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in Cogent Biosciences (COGT) in Q3 2023: 135,000 shares worth $1.31M. The stake represents 0.44% of the portfolio and ranks #45 among its holdings.

135 funds tracked by Wall St. Rank hold COGT as of Q3 2023.

International Biotechnology Trust held 135,000 shares of Cogent Biosciences worth $1.31M as of Q3 2023.
Cogent Biosciences was a new International Biotechnology Trust position in Q3 2023.
Cogent Biosciences made up 0.44% of International Biotechnology Trust's portfolio in Q3 2023, its #45 holding.
135 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.